Abstract |
CC chemokine receptor (CCR) 3 is a chemokine receptor implicated in recruiting cells, particularly eosinophils (EPhi), to the lung in episodes of allergic asthma. To investigate the efficacy of selective, small molecule antagonists of CCR3, we developed a murine model of EPhi recruitment to the lung. Murine eotaxin was delivered intranasally to mice that had previously received i.p. injections of ovalbumin (OVA), and the effects were monitored by bronchoalveolar lavage. A selective eosinophilic influx was produced in animals receiving eotaxin but not saline. Furthermore, the number of EPhi was concentration- and time-dependent. Although anti-CCR3 antibody reduced the number of EPhi, the effect of eotaxin in OVA-sensitized mice was not a direct chemotactic stimulus because mast cell deficiency (in WBB6F1-Kitw/Kitw-v mice) significantly reduced the response. Two representative small molecule CCR3 antagonists from our program were characterized as being active at mouse CCR3. They were administered p.o. to wild-type mice and found to reduce eotaxin-elicited EPhi selectively in a dose-dependent manner. Pump infusion of one of the inhibitors to achieve steady-state levels showed that efficacy was not achieved at plasma concentrations equivalent to the in vitro chemotaxis IC90 but only at much higher concentrations. To extend the results from our recruitment model, we tested one of the inhibitors in an allergenic model of airway inflammation, generated by adoptive transfer of OVA-sensitive murine T helper 2 cells and aerosolized OVA challenge of recipient mice, and found that it inhibited EPhi recruitment. We conclude that small molecule CCR3 antagonists reduce pulmonary eosinophilic inflammation elicited by chemokine or allergenic challenge.
|
Authors | Anuk M Das, Krishna G Vaddi, Kimberly A Solomon, Candice Krauthauser, Xiaosui Jiang, Kim W McIntyre, Xiao Xia Yang, Eric Wadman, Patricia Welch, Maryanne Covington, Danielle Graden, Krishnaswamy Yeleswaram, James M Trzaskos, Robert C Newton, Sandhya Mandlekar, Soo S Ko, Percy H Carter, Paul Davies |
Journal | The Journal of pharmacology and experimental therapeutics
(J Pharmacol Exp Ther)
Vol. 318
Issue 1
Pg. 411-7
(Jul 2006)
ISSN: 0022-3565 [Print] United States |
PMID | 16614169
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CCR3 protein, human
- Ccr3 protein, mouse
- Receptors, CCR3
- Receptors, Chemokine
|
Topics |
- Animals
- CHO Cells
- Cell Migration Inhibition
- Cricetinae
- Disease Models, Animal
- Eosinophils
(drug effects, immunology, metabolism)
- Female
- Humans
- Inflammation
(immunology, metabolism)
- Lung
(immunology, metabolism, pathology)
- Mice
- Mice, Inbred BALB C
- Mice, Knockout
- Receptors, CCR3
- Receptors, Chemokine
(antagonists & inhibitors, immunology, metabolism)
- Respiratory Hypersensitivity
(immunology, metabolism)
|